Rivaroxaban versus Warfarin in Nonvalvular Atrial FibrillationManesh R. Patel, Robert M. Califf, Kenneth W. Mahaffey et al.|New England Journal of Medicine|2011Cited by 9.4k
Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairmentKeith A.A. Fox, Robert M. Califf, Jonathan P. Piccini et al.|European Heart Journal|2011Cited by 614
2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillationStylianos Tzeis, Juan Carlos Díaz, Andrea Natale et al.|EP Europace|2024Cited by 537
Screening for Atrial FibrillationBen Freedman, Jesper Hastrup Svendsen, A. John Camm et al.|Circulation|2017Cited by 535
Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial FibrillationJonathan P. Piccini, Robert M. Califf, Susanna R. Stevens et al.|Circulation|2012Cited by 499